Gsk (GSK) Other Non-Current Assets (2009 - 2026)

As of Dec 31, 2025, Gsk reported Other Assets of $2.89 billion, up 18.7% from the prior year.

• Annual Other Assets has increased for three straight years, with a five-year compound annual growth rate of 15.3% (years ended Dec 2020 to Dec 2025).
• Across earlier years, Other Assets came in at $2.44 billion in the year ended Dec 31, 2024 (+20.8%), $2.02 billion in the year ended Dec 31, 2023 (+40.1%), $1.44 billion in the year ended Dec 31, 2022 (-36.4%) and $2.26 billion in the year ended Dec 31, 2021 (+59.4%).
• Quarterly Other Assets has ranged from $31.53 million in the quarter ended Mar 31, 2022 to $3.52 billion in the quarter ended Jun 30, 2026 over the past five years.
• On a year-over-year basis, Other Assets has increased for 13 consecutive quarters, with growth averaging 21.2% over the last eight quarters.
• Peak year-over-year performance for Other Assets in the last five years was growth of 85.3% in the quarter ended Sep 30, 2024, against a decline of 97.7% in the quarter ended Mar 31, 2022 at the low end.
• Per Business Quant, the preceding three quarters came in at $3.52 billion (quarter ended Jun 30, 2026), $3.11 billion (quarter ended Mar 31, 2026) and $2.89 billion (quarter ended Dec 31, 2025).